Cargando…

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components

[Image: see text] Gene editing mediated by CRISPR/Cas9 systems is due to become a beneficial therapeutic option for treating genetic diseases and some cancers. However, there are challenges in delivering CRISPR components which necessitate sophisticated delivery systems for safe and effective genome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazemian, Pardis, Yu, Si-Yue, Thomson, Sarah B., Birkenshaw, Alexandra, Leavitt, Blair R., Ross, Colin J. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176214/ https://www.ncbi.nlm.nih.gov/pubmed/35594500 http://dx.doi.org/10.1021/acs.molpharmaceut.1c00916

Ejemplares similares

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
por: Rosenblum, Daniel, et al.
Publicado: (2020)

Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
por: Maggio, Ignazio, et al.
Publicado: (2020)

Synthesis and Evaluation of pH-Sensitive Multifunctional Lipids for Efficient Delivery of CRISPR/Cas9 in Gene Editing
por: Sun, Da, et al.
Publicado: (2018)

CRISPR-Cas9: from Genome Editing to Cancer Research
por: Chen, Si, et al.
Publicado: (2016)

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
por: Cheng, Hao, et al.
Publicado: (2021)

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
por: Sinclair, Frazer, et al.
Publicado: (2023)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

A Survey of Validation Strategies for CRISPR-Cas9 Editing
por: Sentmanat, Monica F., et al.
Publicado: (2018)

Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
por: Ju, Hyemin, et al.
Publicado: (2022)

Inducible Genome Editing with Conditional CRISPR/Cas9 Mice
por: Katigbak, Alexandra, et al.
Publicado: (2018)

Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
por: Wei, Tuo, et al.
Publicado: (2020)

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
por: Han, Jeong Pil, et al.
Publicado: (2022)

CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
por: Zhang, Xiaoping, et al.
Publicado: (2019)

Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells
por: Hindriksen, Sanne, et al.
Publicado: (2017)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

CRISPR/Cas9 Essential Gene Editing in Drosophila
por: Osadchiy, I. S., et al.
Publicado: (2023)

Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA
por: Zhang, Xianming, et al.
Publicado: (2022)

Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing
por: Xiu, Kemao, et al.
Publicado: (2022)

Reversible RNA acylation for control of CRISPR–Cas9 gene editing
por: Habibian, Maryam, et al.
Publicado: (2019)

A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
por: Beneke, Tom, et al.
Publicado: (2017)

Targeted delivery of CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for heritable germline gene editing
por: Chaverra-Rodriguez, Duverney, et al.
Publicado: (2018)

Virus-Like Particle Mediated CRISPR/Cas9 Delivery for Efficient and Safe Genome Editing
por: Lyu, Pin, et al.
Publicado: (2020)

High‐efficiency delivery of CRISPR‐Cas9 by engineered probiotics enables precise microbiome editing
por: Neil, Kevin, et al.
Publicado: (2021)

Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System
por: Meneghini, Vasco, et al.
Publicado: (2021)

Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells
por: Lotfi, Malihe, et al.
Publicado: (2023)

Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9
por: Hosseini, Elaheh Sadat, et al.
Publicado: (2019)

Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
por: Feng, Yan, et al.
Publicado: (2016)

FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
por: Cui, Zifeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kq1j0llifadbj1guo5mbna9bsd